Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion type Assertion NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_head.
- NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion description "[The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_provenance.
- NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion evidence source_evidence_literature NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_provenance.
- NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion SIO_000772 17982252 NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_provenance.
- NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion wasDerivedFrom befree-20140225 NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_provenance.
- NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_assertion wasGeneratedBy ECO_0000203 NP583952.RAWfJRXI4otg6HVo2lYqGdIKn2SKZ-24FazPtA2ephq3s130_provenance.